ICU Medical Q2 2021 Earnings Report
Key Takeaways
ICU Medical announced its second quarter 2021 results, with revenue reaching $321.7 million compared to $303.4 million in the same period last year. GAAP net income was $28.4 million, or $1.31 per diluted share, compared to $18.9 million, or $0.88 per diluted share, for the second quarter of 2020. The company updated its full year 2021 guidance for adjusted EBITDA and adjusted diluted earnings per share.
Second quarter revenue was $321.7 million, up from $303.4 million in the same period last year.
GAAP gross profit for the second quarter was $123.5 million, compared to $106.3 million in the same period last year.
GAAP net income for the second quarter was $28.4 million, or $1.31 per diluted share, compared to $18.9 million, or $0.88 per diluted share, for the second quarter of 2020.
Adjusted diluted earnings per share for the second quarter were $1.88, compared to $1.65 for the second quarter of 2020.
ICU Medical
ICU Medical
ICU Medical Revenue by Segment
Forward Guidance
The company is updating its full year 2021 guidance of adjusted EBITDA from a range of $245 million to $265 million to a range of $250 million to $260 million and adjusted diluted earnings per share from a range of $6.50 to $7.20 to a range of $6.80 to $7.20.
Revenue & Expenses
Visualization of income flow from segment revenue to net income